Clinical Outcomes in Men of Diverse Ethnic Backgrounds with Metastatic Castration Resistant Prostate Cancer

BACKGROUND: We have shown previously in multivariable analysis that black men had 19% lower risk of death than white men with metastatic castration resistant prostate cancer (mCRPC) treated with a docetaxel (D) and prednisone (P)-based regimen. The primary goal of this analysis was to compare progre...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Ann Oncol
Главные авторы: Halabi, S., Dutta, S., Tangen, C.M., Rosenthal, M., Petrylak, D. P., Thompson, I. M., Chi, K.N., De Bono, J. S., Araujo, J. C., Logothetis, C., Eisenberger, M.A., Quinn, D. I., Fizazi, K., Morris, M. J., Higano, C. S., Tannock, I. F., Small, E. J., Kelly, W.K.
Формат: Artigo
Язык:Inglês
Опубликовано: 2020
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC7580036/
https://ncbi.nlm.nih.gov/pubmed/32289380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.annonc.2020.03.309
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы